Ads
related to: roche stock quoteschwab.com has been visited by 100K+ users in the past month
- thinkorswim®
Access The Award-Winning Platform
Built By Traders, For Traders.
- Pricing for Online Trades
No Account Fees or Platform Fees
With Schwab's Trading Services.
- Start Trading Today
Open Your Brokerage Account With
Schwab For No Trade Minimums.
- Trading At Schwab
Now Powered By Ameritrade.
Learn More.
- Get $101 To Invest
Open An Eligible Account With $50
And Get $101 Of Stock Slices.
- Schwab Investing Themes™
Invest In Ideas You Believe In -
Choose From Over 40 Themes.
- thinkorswim®
Search results
Roche Holding (VTX:ROG) investors are sitting on a loss of 19% if they invested a year ago
Simply Wall St. via Yahoo Finance· 8 months agoThe simplest way to benefit from a rising market is to buy an index fund. Active investors aim to...
The Zacks Analyst Blog Highlights Stocks recently featured in the blog include: Novo Nordisk, Eli...
Zacks via Yahoo Finance· 1 month agoFor Immediate Releases Chicago, IL – May 20, 2024 – Zacks.com announces the list of stocks featured...
Roche (RHHBY) Up on Upbeat Data From Combo Drug Cancer Study
Zacks via Yahoo Finance· 10 months agoRoche's (RHHBY) stock jumps 4.3% on Wednesday after the company inadvertently publishes encouraging...
Roche (RHHBY) & Lilly to Co-Develop Alzheimer's Detection Device
Zacks via Yahoo Finance· 1 year agoRoche Holding AG RHHBY announced a collaboration with Eli Lilly and Company LLY where the latter...
Roche's (RHHBY) Combination Therapy Meets Goal in Lymphoma Study
Zacks via Yahoo Finance· 2 months agoRoche Holding AG RHHBY announced that the late-stage study evaluating its marketed drug, Columvi...
Roche's (RHHBY) Hemophilia A Drug Gets Positive CHMP Opinion
Zacks via Yahoo Finance· 2 years agoRoche RHHBY announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products...
Roche's (RHHBY) Lunsumio Application Gets Priority Review
Zacks via Yahoo Finance· 2 years agoRoche's (RHHBY) BLA application seeking approval for the use of Lunsumio for relapsed or refractory...
Roche Holding's (VTX:ROG) investors will be pleased with their favorable 47% return over the last...
Simply Wall St. via Yahoo Finance· 2 years agoGenerally speaking the aim of active stock picking is to find companies that provide returns that...
Roche's (RHHBY) Lunsumio Gets FDA Nod for Follicular Lymphoma
Zacks via Yahoo Finance· 1 year agoRoche RHHBY announced that the FDA approved intravenously-administered Lunsumio (mosunetuzumab) for...
Roche's (RHHBY) Vabysmo Positive in Late-Stage RVO Studies
Zacks via Yahoo Finance· 8 months agoRoche (RHHBY) Vabysmo maintains vision improvements with extended treatment intervals of up to four...